1. Bristol Myers Squibb
2. Merck
3. Eli Lilly
4. Sino BioPharma
5. F Hoffmann-La Roche AG
6. Johnson & Johnson
7. AbbVie Inc.
8. AstraZeneca plc
Published | Pages | Publisher | Report code |
---|---|---|---|
Oct 2023 | 130 | Renub Research | ASDR-637375 |
1. Bristol Myers Squibb
2. Merck
3. Eli Lilly
4. Sino BioPharma
5. F Hoffmann-La Roche AG
6. Johnson & Johnson
7. AbbVie Inc.
8. AstraZeneca plc